248919-64-4 Usage
Uses
Used in Pharmaceutical Industry:
Linaprazan is used as a medication for treating conditions related to excessive stomach acid production, such as gastroesophageal reflux disease (GERD), ulcers, and other digestive disorders. It works by inhibiting the activity of proton pumps in the stomach, thereby reducing the amount of acid produced and providing relief from symptoms associated with these conditions.
Used in Gastroenterology:
Linaprazan is used as a therapeutic agent in gastroenterology for managing patients with GERD, peptic ulcers, and other acid-related disorders. Its ability to block acid production makes it an effective treatment option for patients experiencing heartburn, regurgitation, and other symptoms of GERD, as well as for those with ulcers caused by Helicobacter pylori infection or nonsteroidal anti-inflammatory drug (NSAID) use.
Used in Long-term Management of Acid-related Disorders:
Linaprazan is used as a long-term management option for patients with chronic acid-related disorders. Its sustained effect on reducing stomach acid production helps in maintaining remission and preventing relapses, thus improving the quality of life for individuals suffering from these conditions.
Used in Combination Therapy:
Linaprazan is also used in combination therapy with other medications, such as antibiotics and H2 receptor antagonists, for the treatment of Helicobacter pylori infection, which is a common cause of peptic ulcers. This combination approach enhances the eradication of the bacteria and promotes healing of the ulcers, leading to better patient outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 248919-64-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,8,9,1 and 9 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 248919-64:
(8*2)+(7*4)+(6*8)+(5*9)+(4*1)+(3*9)+(2*6)+(1*4)=184
184 % 10 = 4
So 248919-64-4 is a valid CAS Registry Number.
248919-64-4Relevant academic research and scientific papers
IMIDAZOPYRIDINE DERIVATIVES WHICH INHIBIT THE SECRETION OF GASTRIC ACID
-
Page/Page column 14-15, (2010/06/20)
The present invention relates to substituted imidazo [1,2-a]pyridines of formula I where R is -CH2COOH or -COOH, which inhibits exogenously or endogenously stimulated gastric acid secretion and can be used in the prevention and treatment of gastric acid related diseases and gastrointestinal inflammatory diseases.
